Moderna COVID-19 vaccine (redirect from Spikevax) The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National... 165 KB (13,017 words) - 17:59, 27 April 2024 |
with Moderna for fill-finish, packaging and labeling of its mRNA vaccine, Spikevax, during the COVID-19 pandemic. Founded in 2011, Samsung Biologics built... 10 KB (713 words) - 10:20, 24 March 2024 |
2020. "EMA recommends standard marketing authorizations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency. 16 September 2022. Archived... 192 KB (22,021 words) - 19:29, 15 April 2024 |
which the first authorized were COVID-19 vaccines (such as Comirnaty and Spikevax). mRNA is produced by synthesising a ribonucleic acid (RNA) strand from... 24 KB (2,503 words) - 11:29, 22 February 2024 |
Turkey[unreliable source?] The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S.... 318 KB (19,351 words) - 20:00, 21 April 2024 |
world. Brand Institute also developed the COVID-19 vaccine brand names Spikevax (Moderna), Vaxzevria (AstraZeneca), and Nuvaxovid (Novavax). Brand Institute's... 10 KB (885 words) - 15:16, 23 April 2024 |
2016. "Myokarditt hos gutter og unge menn kan forekomme oftere etter Spikevax-vaksinen fra Moderna". October 6, 2021. Archived from the original on January... 6 KB (481 words) - 11:22, 11 April 2024 |
mRNA-1283 Vaccine description Target SARS-CoV-2 Vaccine type mRNA Clinical data Trade names Spikevax Routes of administration Intramuscular... 4 KB (275 words) - 09:58, 30 December 2023 |
announced that it would bring forward the rollout of the bivalent Moderna/Spikevax COVID-19 vaccine three days to 14 October, due to the spike in infections... 62 KB (2,614 words) - 17:07, 2 April 2024 |
Sweden phase III clinical trials 18 March 2021 22 March 2021 Moderna Spikevax Moderna United States phase III clinical trials 5 May 2021 9 June 2021... 62 KB (5,790 words) - 01:49, 16 March 2024 |
Retrieved 14 April 2022. "MHRA approves the Moderna COVID-19 vaccine 'Spikevax' for use in 6 to 11-year olds". Gov.uk. 14 April 2022. Retrieved 14 April... 275 KB (30,526 words) - 01:02, 28 April 2024 |
COVID-19 vaccine for youngest kids". CBC News. "Regulatory Decision Summary - Spikevax - Health Canada". Health Canada. Archived from the original on 2022-07-16... 150 KB (8,473 words) - 05:20, 15 October 2023 |